Other lipid-modifying drugs by all Sub-ICB Locations

Why it matters: NICE guidance suggests that, for the vast majority of people who need treatment for high cholesterol, these drugs should not be used. There is no evidence that omega 3 fatty acids reduce the chances of patients getting cardiovascular disease.

Description: Total cost of prescriptions for bile acid sequestrants, fibrates, nicotinic acid, and omega-3 fatty acid compounds per 1000 registered patients

Performance: Loading...

Explore:

Tagged as: Cardiovascular system, Standard, Efficacy, NICE (or browse all measures)

Sub-ICB Locations are ordered by mean percentile over the past six months. Each chart shows the results for the individual Sub-ICB Location, plus deciles across all Sub-ICB Locations in the NHS in England.

View measure for NHS England combined →



Fetching data...

Do you need help with your analysis? Don't forget to check the FAQ page, and if you have questions.